| Submit your comments on this article |
| Science & Technology |
| Israel says signed MOU with NRX Pharmaceuticals for COVID vaccine trials |
| 2021-07-12 |
| [YNet] - Israel has signed a memorandum of understanding with NRX Pharmaceuticals to complete trials and commercialize the Israeli-developed COVID-19 vaccine BriLife, the Defense Ministry said on Monday. The vaccine was developed by the Israel Institute for Biological Research, which is overseen by the Defense Ministry. Because if one needs a booster shot every few months, Pfizer becomes, just a tad, too expensive. Also, there should be a large market in countries currently using Sinodreck. |
| Posted by:g(r)omgoru |
| #1 |
| Posted by: trailing wife 2021-07-12 14:43 |